P2 D Bioscience
Pharmaceuticals, 3130 Highland Ave, Cincinnati, Ohio, 45219, United States, 1-10 Employees
Who is P2D BIOSCIENCE
P2D Bioscience (P2D) is a specialty pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) and pul...
Read More
-
Headquarters: 3130 Highland Ave, Cincinnati, Ohio, 45219, United States
-
Date Founded: 2005
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 8731
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from P2D BIOSCIENCE
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding P2D Bioscience
Answer: P2D Bioscience's headquarters are located at 3130 Highland Ave, Cincinnati, Ohio, 45219, United States
Answer: P2D Bioscience's official website is https://p2dinc.com
Answer: P2D Bioscience's revenue is Under $1 Million
Answer: P2D Bioscience's SIC: 8731
Answer: P2D Bioscience's NAICS: 325412
Answer: P2D Bioscience has 1-10 employees
Answer: P2D Bioscience is in Pharmaceuticals
Answer: P2D Bioscience contact info: Phone number: Website: https://p2dinc.com
Answer: P2D Bioscience (P2D) is a specialty pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) and pulmonary disorders including attention deficit/hyperactivity disorder (ADHD), obesity, anxiety, depression, Alzheimers disease, traumatic brain injury and chronic obstructive pulmonary disease (COPD). At P2D, our experienced drug development team utilizes our in-depth understanding of the clinical treatment of CNS disorders and neurodegenerative diseases to efficiently build a product portfolio of therapeutics with an improved likelihood for clinical success. Our goal is to advance a product candidate through preclinical development and clinical proof-of-concept by producing powerful and compelling clinical data and then seeking partners to complete the clinical development and commercialization process. P2D currently has a pipeline of nine drug candidates to treat ADHD, obesity and diabetes, Alzheimers disease, traumatic brain injury and COPD.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month